Navigation Links
ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
Date:9/24/2007

ST. LOUIS, Sept. 24 /PRNewswire/ -- ISTO Technologies Inc., a privately held orthobiologics company, today announced that the United States Food and Drug Administration has granted 510(k) clearance for InQu(TM). InQu is indicated for use as a bone graft extender in the spine and as a bone graft substitute in the extremities and pelvis.

InQu represents a new class of synthetic biomaterial scaffold designed to optimize structural and biological properties to support bone cell growth. InQu is a biopolymer composite of hyaluronic acid which is entangled within the three-dimensional backbone created by synthetic polyester. Hyaluronic acid, a ubiquitous component of natural tissue, is known to play a predominant role in tissue morphogenesis, cell migration, adhesion, and cell differentiation. Mitchell Seyedin, President and CEO of ISTO said, "We are very pleased to receive FDA clearance and will focus on demonstrating InQu's clinical benefit to the surgeons and patients."

More than 1 million bone grafting procedures are performed in the United States annually, and more than 3 million procedures are performed worldwide. Synthetic bone graft material represents the fastest growing segment of the orthobiologics market. "We are very excited to participate in this evolving market with our exceptional product," adds Seyedin. ISTO intends to launch InQu at the upcoming annual North American Spine Society conference in Austin, Texas.

In addition to its biomaterial platform technology, ISTO is also developing cartilage regeneration products centered on its patented cell-based technology. Cartilage regeneration is often called the "holy grail" of the orthopedic industry because of its potential to restore function to damaged joints that otherwise have limited healing potential. Cartilage serves as a "shock absorber" protecting all joints, including spinal discs, from the wear and tear experienced during motion. ISTO's first cartilage product is currently in
'/>"/>

SOURCE ISTO Technologies Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Researchers Develop Technologies to Devour Food Pathogens
2. Researchers Study Safety of Assisted Reproductive Technologies
3. India to Propose Global Fund for Clean Energy Technologies
4. Infant receives first bloodless liver transplant
5. British MPs Say Prostate Cancer Receives Low Priority in the NHS
6. Fifth US Patient Receives Artificial Heart
7. Northfield Labs Receives FDA Comments
8. Abbott Receives CE Mark Certification
9. Zactima Receives Fast Track Designation By The FDA
10. East London Receives World Class New Private Hospital Facility
11. Brinda Karat Receives Legal Notice over Ramdev Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Amy Norton HealthDay Reporter ... fare better when newborn intensive care units (NICU) set up ... a new study finds. Researchers at one children,s hospital ... were less distressed when their NICU switched from the traditional ... published online Sept. 22 in the journal Pediatrics , ...
(Date:9/22/2014)... a founding partner in the Global STEM Alliance, a ... talent in science, technology, engineering and math (STEM) around ... of Sciences (NYAS), Malaysian Prime Minister Najib Razak participated ... , With the goal of developing over 1,000,000 aspiring ... the initiative will create a host of learning opportunities, ...
(Date:9/22/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/22/2014)... York, New York (PRWEB) September 22, 2014 ... associated with the use of power morcellators ( ... LLP notes a new report detailing the continued ... warnings from federal regulators that specifically discouraged these ... physicians believe that the potential cancer risks associated ...
(Date:9/22/2014)... Shippensburg, PA (PRWEB) September 22, 2014 Pain ... Your Chronic Pain” is a user- and reader-friendly book designed ... way back to pain-free living. This inspirational book is written ... and desires to know a way to regain a pain-free ... the prison of chronic pain. , Chronic pain has become ...
Breaking Medicine News(10 mins):Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2
... Francisco's 2002 Gay Pride, San Francisco Department of Public Health ... ,In the above said campaign, a cartoon penis by ... hundreds of homo whores who had gathered there to get ... were not happy with the Ad and scoffed at the ...
... habits, is easily acquired but quite difficult to stop.// All ... or at least have to try out recommended smoking cessation ... the ages of 16 and 24 years do try to ... try out tested methods. ,An article presented in ...
... A US company claimed to have developed a weight reduction ... also could cut the risk of heart disease, diabetes and ... five to 10 percent when taken for a year. ... developed by Californian biopharmaceutical firm Orexigen for 48 weeks lost ...
... apple and plum, now strawberry wine will add variety from ... the Horticulture Produce Marketing Corp's (HPMC) juice and wine processing ... ,The new wine was produced after year-long research by experts ... town Kalpa in Kinnaur district, which produces some of the ...
... Systemic sclerosis (SSc) is a chronic autoimmune disorder ... tissue fibrosis.// More than skin deep, this thickening ... capillaries, the gastrointestinal tract, the lungs, and the ... organ dysfunction, serious illness, and death. Researchers have ...
... better safety for patients in ICU by adhering to ... threatening// catheter-related infections. ICUs can become thoroughly aseptic by ... syringes and catheters. A detailed report was made by ... of the report are published in New England Journal ...
Cached Medicine News:Health News:Tried To Quit Smoking And Failed? Call 1-800-QUIT-NOW 2Health News:New Treatment Offers Hope for Systemic Sclerosis 2Health News:Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU 2
(Date:9/22/2014)... Sept. 22, 2014 Children,s National Health ... Sept. 29 at 5 p.m. EDT for its ... in response to continued strong interest from inventors.  ... will be awarded to the winning presentations at ... Symposium hosted by Children,s National in October. For ...
(Date:9/22/2014)... 22, 2014 Persistence Market Research ... Market Study on Ophthalmic Devices: Asia ... devices market was valued at USD 29,171.5 million in 2014 ... 6.5% from 2014 to 2020, to reach an estimated ... Browse the full Global Market Study on Ophthalmic Devices:  ...
(Date:9/22/2014)... , Sept. 22, 2014 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products, is ... Biomedical Inc. ("Thunderbird"), has signed a definitive lease agreement ... , BC.  The facility has 28,966 square feet ... 14,500 square feet of mezzanine space for a total ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3
... CPF Calls on Manufacturer and FDA to Expedite Review of ... The Coalition for Pulmonary Fibrosis (CPF) is calling this a ... a pivotal Phase III clinical trial is completed for Pirfenidone ... way for the first FDA-approved therapy to treat PF - ...
... Intellectual property based on breakthrough research from a ... Montreal Heart Institute Research Centre, Canada.TOULOUSE, France and ... SA (Cerenis), a privately held pharmaceutical company developing ... metabolic diseases, today announced that it has in-licensed ...
Cached Medicine Technology:Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis 2Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis 3Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis 2
... and high power negative lens delivering magnification ... benefit of this system is ease of ... made possible due to a superior depth ... and individual interpupillary adjustment provides stability for ...
... represents a breakthrough for patients experiencing degenerative ... system gathers bone during decompression, bone bed ... into the implant's chamber produces a local ... the iliac crest. The BAK/C implant is ...
Inside and out, the Achieva is designed to unleash a new era, in which the clinical capabilities of MR will further expand....
Signa Profile is built on the Signa foundation to deliver speed & image quality....
Medicine Products: